Biocon Limited

BSE : 532523 | NSE : BIOCON
Industry : Pharmaceuticals | ISIN : INE376G01013 | FreeFloat : 32.29% | FnO : Yes | LotSize : 2300
Intellectual Capital (IC)1,033.61
Net Worth (NW)11,027.30
Intrinsic Worth (IW)12,060.91
Market Cap (MC)31,437.71
Economic Value Added-257.89
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)8.57%
IC Gross Margin (EBITDA/IC)223.71%
IC Net Margin (NPT/IC)80.72%
Knowledge Turnover (Sales/IC)10.05
Market to Intrinsic Value (MC/IW)2.61
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 100.46Rs. 261.85
20 Mar 2023 ---- Rs. 201.75
-0.55     -0.27%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 218.07SellStrong Sell
KB > 50% : No50 DMA : Rs. 234.96
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
1581.00
1644.10
373.30
220.90
204.10
123.40
72.10
Jun-20
C
1671.30
1689.60
431.60
264.80
252.30
167.80
137.00
Sep-20
C
1744.80
1760.30
406.90
229.20
222.70
195.40
276.60
Dec-20
C
1851.00
1878.90
427.40
241.10
236.30
186.60
189.89
Mar-21
C
1838.70
2044.10
584.30
400.00
366.10
296.40
358.30
Jun-21
C
1760.60
1807.80
380.40
185.60
165.70
108.40
102.40
Sep-21
C
1840.40
1945.30
430.00
228.50
206.00
159.70
224.80
Dec-21
C
2174.20
2222.50
489.30
283.60
268.90
219.60
270.60
Mar-22
C
2408.80
2476.10
606.20
394.00
383.50
283.90
339.80
Jun-22
C
2139.50
2217.40
434.30
216.80
196.90
167.40
118.90
Sep-22
C
2319.70
2384.20
506.90
276.10
246.10
81.80
104.20
Dec-22
C
2941.10
3019.70
667.30
366.20
245.90
-20.70
187.60
* C - Consolidated, S - Standalone